![](/img/cover-not-exists.png)
392 PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
Satish Keshav, Daniel Johnson, Pirow Bekker, Thomas J. SchallVolume:
136
Year:
2009
Language:
english
DOI:
10.1016/s0016-5085(09)60295-x
File:
PDF, 123 KB
english, 2009